ArticleOpen veterinary journal2025
Protective effect of epigallocatechin-gallate in cryopreserved goat sperm on post-thawed quality.
Article in Open veterinary journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cryopreservation is a useful technique for preserving goat sperm, but it often causes damage due to oxidative stress triggered by increased reactive oxygen species. One promising solution is the use of antioxidants, such as epigallocatechin gallate (EGCG), to reduce these harmful effects. EGCG has been recognised for its ability to safeguard sperm cells by supporting the normal function of mitochondria, regulating cell death mechanisms, and supporting genes involved in energy metabolism. Aim: This study aimed to evaluate the effects of different concentrations of EGCG added to semen extenders on the quality of goat sperm after thawing, including motility, viability, and the expression of genes related to mitochondrial activity and apoptosis. Methods: Several concentrations of EGCG (ranging from 50-800 mg/dl) were tested. Post-thaw sperm motility and viability were analysed using Open CASA Results: The findings showed that 200 mg/dl of EGCG significantly improved sperm motility, while the 100 mg/dl dose helped maintain better viability after thawing. Interestingly, BCL-2 expression increased most notably at 500 mg/dl, indicating anti-apoptotic protection. Additionally, CPT2 gene expression was significantly upregulated at EGCG concentrations of 50, 100, 400, and 800 mg/dl compared to the control group. Conclusion: EGCG supplementation in goat semen extenders has a protective effect on post-thawed sperm by improving motility and viability and supporting mitochondrial and apoptotic pathways. These results suggest that EGCG can be a valuable additive for enhancing artificial insemination outcomes in goats.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.